{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:21:38Z","timestamp":1785882098317,"version":"3.56.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["PSR2022_DIP_022_AZIONE_A_ABARA"],"award-info":[{"award-number":["PSR2022_DIP_022_AZIONE_A_ABARA"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.tips.2024.12.003","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:11:44Z","timestamp":1737648704000},"page":"102-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring neutrophils as therapeutic targets in cardiometabolic diseases"],"prefix":"10.1016","volume":"46","author":[{"given":"Mattia","family":"Albiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-1999","authenticated-orcid":false,"given":"Andrea","family":"Baragetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2024.12.003_bb0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week","volume":"82","author":"Nelson","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2024.12.003_bb0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tips.2024.12.003_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2024.12.003_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/imr.13142","article-title":"The role of neutrophils in trained immunity","volume":"314","author":"Kalafati","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tips.2024.12.003_bb0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41586-024-07693-6","article-title":"Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming","volume":"634","author":"Lavillegrand","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2024.12.003_bb0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0035","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0040","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","article-title":"Neutrophil counts and cardiovascular disease","volume":"44","author":"Luo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2024.12.003_bb0045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil\u2013lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials","volume":"42","author":"Adamstein","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2024.12.003_bb0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41569-019-0326-7","article-title":"Neutrophils as regulators of cardiovascular inflammation","volume":"17","author":"Silvestre-Roig","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2024.12.003_bb0055","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCRESAHA.120.315895","article-title":"Hematopoiesis and cardiovascular disease","volume":"126","author":"Poller","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","article-title":"Neutrophils as emerging therapeutic targets","volume":"19","author":"N\u00e9meth","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2024.12.003_bb0065","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/cvr\/cvab302","article-title":"Neutrophils in cardiovascular disease: warmongers, peacemakers, or both?","volume":"118","author":"Sreejit","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0070","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2020.10.003","article-title":"Co-option of neutrophil fates by tissue environments","volume":"183","author":"Ballesteros","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.12.003_bb0075","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1084\/jem.20181468","article-title":"Neutrophils instruct homeostatic and pathological states in naive tissues","volume":"215","author":"Casanova-Acebes","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0080","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/s41467-021-22973-9","article-title":"The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments","volume":"12","author":"Grieshaber-Bouyer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2024.12.003_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107058","article-title":"Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?","volume":"200","author":"Domingo","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1334205","article-title":"A metabolic perspective of the neutrophil life cycle: new avenues in immunometabolism","volume":"14","author":"Thind","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2024.12.003_bb0095","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20210014","article-title":"Effect of lipids and lipoproteins on hematopoietic cell metabolism and commitment in atherosclerosis","volume":"3","author":"Baragetti","year":"2021","journal-title":"Immunometabolism"},{"key":"10.1016\/j.tips.2024.12.003_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev-physiol-052521-013627","article-title":"Inflammatory modulation of hematopoiesis: linking trained immunity and clonal hematopoiesis with chronic disorders","volume":"84","author":"Chavakis","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.tips.2024.12.003_bb0105","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/db19-0080","article-title":"Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway","volume":"68","author":"Albiero","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2024.12.003_bb0110","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1210\/jc.2005-1619","article-title":"Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans","volume":"91","author":"Walrand","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0115","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2337\/db12-1648","article-title":"SIRT1, p66(Shc), and Set7\/9 in vascular hyperglycemic memory: bringing all the strands together","volume":"62","author":"Paneni","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2024.12.003_bb0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(19)30154-8","article-title":"SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tips.2024.12.003_bb0125","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/db20-1045","article-title":"Inhibition of SGLT2 rescues bone marrow cell traffic for vascular repair: role of glucose control and ketogenesis","volume":"70","author":"Albiero","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2024.12.003_bb0130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.2019004465","article-title":"Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor","volume":"136","author":"Wortmann","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tips.2024.12.003_bb0135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/jha2.649","article-title":"Finding balance between mature and immature neutrophils: the effects of empagliflozin in GSD-Ib","volume":"4","author":"Guerra","year":"2023","journal-title":"EJHaem"},{"key":"10.1016\/j.tips.2024.12.003_bb0140","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tips.2024.12.003_bb0145","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00592-018-1129-8","article-title":"The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo","volume":"55","author":"Menegazzo","year":"2018","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.tips.2024.12.003_bb0630","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00592-014-0676-x","article-title":"NETosis is induced by high glucose and associated with type 2 diabetes","volume":"52","author":"Menegazzo","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.tips.2024.12.003_bb0635","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0775","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/db15-0863","article-title":"NETosis delays diabetic wound healing in mice and humans","volume":"65","author":"Fadini","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2024.12.003_bb0150","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cmet.2014.03.029","article-title":"Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity","volume":"19","author":"Nagareddy","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0155","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCRESAHA.117.312200","article-title":"CANTOS: a gigantic proof-of-concept trial","volume":"121","author":"Iba\u00f1ez","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0160","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41577-021-00580-5","article-title":"Immune-based therapies in cardiovascular and metabolic diseases: past, present and future","volume":"21","author":"Murphy","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tips.2024.12.003_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173349","article-title":"Pleiotropic effects of anti-diabetic drugs: a comprehensive review","volume":"884","author":"Nath","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2024.12.003_bb0170","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cell.2013.04.040","article-title":"Rhythmic modulation of the hematopoietic niche through neutrophil clearance","volume":"153","author":"Casanova-Acebes","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.12.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155576","article-title":"Neutrophil aging exacerbates high fat diet induced metabolic alterations","volume":"144","author":"Baragetti","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.tips.2024.12.003_bb0180","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/db19-0640","article-title":"Pharmacologic PPAR-\u03b3 activation reprograms bone marrow macrophages and partially rescues HSPC mobilization in human and murine diabetes","volume":"69","author":"Tedesco","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2024.12.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114517","article-title":"Dipeptidyl peptidase 4 inhibitors: applications in innate immunity?","volume":"188","author":"Yazbeck","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2024.12.003_bb0190","doi-asserted-by":"crossref","first-page":"E414","DOI":"10.1152\/ajpendo.00418.2014","article-title":"Increased GIP signaling induces adipose inflammation via a HIF-1\u03b1-dependent pathway and impairs insulin sensitivity in mice","volume":"308","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0195","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00125-015-3618-4","article-title":"GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial","volume":"58","author":"G\u00f6gebakan","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2024.12.003_bb0200","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","article-title":"The expanding incretin universe: from basic biology to clinical translation","volume":"66","author":"Drucker","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2024.12.003_bb0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0031-1271777","article-title":"Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents","volume":"43","author":"Dokken","year":"2011","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0210","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11010-023-04784-2","article-title":"Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression","volume":"479","author":"Pan","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tips.2024.12.003_bb0215","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s42255-023-00811-0","article-title":"The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets","volume":"5","author":"El","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/dom.14553","article-title":"The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: a post hoc analysis","volume":"24","author":"Wilson","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0225","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications","volume":"21","author":"Ference","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2024.12.003_bb0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.12.003_bb0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cvr\/cvae034","article-title":"Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials","volume":"120","author":"Xie","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8732360","article-title":"Effect of statins on serum level of hs-CRP and CRP in patients with cardiovascular diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"2022","author":"Kandelouei","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.tips.2024.12.003_bb0245","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.hlc.2023.04.300","article-title":"The effects of statins on cardiovascular and inflammatory biomarkers in primary prevention: a systematic review and meta-analysis","volume":"32","author":"He","year":"2023","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.tips.2024.12.003_bb0250","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00125-023-05990-9","article-title":"Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes","volume":"66","author":"Oostveen","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.tips.2024.12.003_bb0255","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00259-018-4038-8","article-title":"Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET\/CT","volume":"45","author":"Verweij","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.tips.2024.12.003_bb0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacl.2017.10.019","article-title":"Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia","volume":"12","author":"Toutouzas","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.tips.2024.12.003_bb0265","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1093\/eurheartj\/ehab465","article-title":"Impact of cholesterol on proinflammatory monocyte production by the bone marrow","volume":"42","author":"Stiekema","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2024.12.003_bb0270","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.12.003_bb0275","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/cvr\/cvaa077","article-title":"Effect of inclisiran, the small-interfering RNA against proprotein convertase subtilisin\/kexin type 9, on platelets, immune cells, and immunological biomarkers: a pre-specified analysis from ORION-1","volume":"117","author":"Landmesser","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0280","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00592-021-01703-z","article-title":"Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting","volume":"58","author":"Scicali","year":"2021","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.tips.2024.12.003_bb0285","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.jcmg.2019.06.022","article-title":"PCSK9 antibody alirocumab attenuates arterial wall inflammation without changes in circulating inflammatory markers","volume":"12","author":"Hoogeveen","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.tips.2024.12.003_bb0290","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/ATVBAHA.123.319272","article-title":"Effect of PCSK9 inhibition on the plasma proteome: A SPIRE substudy","volume":"43","author":"Kraaijenhof","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2024.12.003_bb0295","first-page":"434","article-title":"Dietary fats as regulators of neutrophil plasticity: an update on molecular mechanisms","volume":"27","author":"Parolini","year":"2024","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.tips.2024.12.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1177\/14791641211032547","article-title":"The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: a Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study","volume":"18","author":"Ong","year":"2021","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114629","article-title":"Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution","volume":"162","author":"Sherratt","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2024.12.003_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-022-01075-x","article-title":"Role of omega-3 fatty acids in cardiovascular disease: the debate continues","volume":"25","author":"Sherratt","year":"2023","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.tips.2024.12.003_bb0320","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MOH.0000000000000822","article-title":"Lipid mediators in neutrophil biology: inflammation, resolution and beyond","volume":"31","author":"Ghodsi","year":"2024","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.tips.2024.12.003_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2021.102337","article-title":"Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability","volume":"173","author":"Sherratt","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.tips.2024.12.003_bb0330","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.bpj.2021.04.009","article-title":"EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol","volume":"120","author":"Jacobs","year":"2021","journal-title":"Biophys. J."},{"key":"10.1016\/j.tips.2024.12.003_bb0335","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11883-021-00972-x","article-title":"Monoclonal antibodies in the management of familial hypercholesterolemia: focus on PCSK9 and ANGPTL3 inhibitors","volume":"23","author":"Pirillo","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.tips.2024.12.003_bb0340","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/cvr\/cvad177","article-title":"Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance","volume":"119","author":"Packard","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0345","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0350","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2022.04.009","article-title":"Beyond fibrinolysis: the confounding role of Lp(a) in thrombosis","volume":"349","author":"Boffa","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tips.2024.12.003_bb0355","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2022.04.004","article-title":"Lipoprotein(a): an underestimated inflammatory mastermind","volume":"349","author":"Dzobo","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tips.2024.12.003_bb0360","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/ATVBAHA.123.319937","article-title":"Diacylglycerols and lysophosphatidic acid, enriched on lipoprotein(a), contribute to monocyte inflammation","volume":"44","author":"Dzobo","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2024.12.003_bb0365","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14254","article-title":"New insights into the therapeutic options to lower lipoprotein(a)","volume":"54","author":"Baragetti","year":"2024","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.tips.2024.12.003_bb0370","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of interleukin-1\u03b2 inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2024.12.003_bb0375","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","article-title":"Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes","volume":"71","author":"Everett","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2024.12.003_bb0380","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/db14-0443","article-title":"CXCR1\/2 inhibition blocks and reverses type 1 diabetes in mice","volume":"64","author":"Citro","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2024.12.003_bb0385","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/dom.14770","article-title":"Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2 , in new-onset type 1 diabetes: a multicentre, randomized, double-blind, placebo-controlled trial","volume":"24","author":"Piemonti","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0390","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0395","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.51927","article-title":"Clonal hematopoiesis risk score and all-cause and cardiovascular mortality in older adults","volume":"7","author":"Saadatagah","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tips.2024.12.003_bb0400","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10557-020-06943-9","article-title":"Inhibition of JAK2 suppresses myelopoiesis and atherosclerosis in Apoe\u2013\/\u2013 mice","volume":"34","author":"Tang","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.tips.2024.12.003_bb0405","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/ATVBAHA.120.315369","article-title":"Apoptotic ablation of platelets reduces atherosclerosis in mice with diabetes","volume":"41","author":"Lee","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2024.12.003_bb0410","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tips.2024.12.003_bb0415","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2024.12.003_bb0420","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1093\/cvr\/cvab231","article-title":"From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?","volume":"117","author":"Ridker","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0425","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s44161-023-00281-3","article-title":"Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis","volume":"2","author":"Liu","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0430","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jacbts.2021.04.002","article-title":"High-fat diet enhances neutrophil adhesion in LDLR-null mice via hypercitrullination of histone H3","volume":"6","author":"Osaka","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.tips.2024.12.003_bb0435","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41586-024-07803-4","article-title":"DNA-sensing inflammasomes cause recurrent atherosclerotic stroke","volume":"633","author":"Cao","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2024.12.003_bb0440","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/ATVBAHA.120.314807","article-title":"NETosis is required for S100A8\/A9-induced granulopoiesis after myocardial infarction","volume":"40","author":"Nagareddy","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2024.12.003_bb0445","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.117.312494","article-title":"Roles of PAD4 and NETosis in experimental atherosclerosis and arterial injury: implications for superficial erosion","volume":"123","author":"Franck","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0450","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0455","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine--update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.tips.2024.12.003_bb0460","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2024.12.003_bb0465","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/annrheumdis-2020-219174","article-title":"Anti-inflammatory therapy for COVID-19 infection: the case for colchicine","volume":"80","author":"Reyes","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.tips.2024.12.003_bb0470","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","article-title":"Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease: a LoDoCo2 proteomic substudy","volume":"142","author":"Opstal","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2024.12.003_bb0475","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0480","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0485","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2014.04.021","article-title":"CXCR4 blockade induces atherosclerosis by affecting neutrophil function","volume":"74","author":"Bot","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.tips.2024.12.003_bb0490","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cmet.2018.05.002","article-title":"Chrono-pharmacological targeting of the CCL2-CCR2 axis ameliorates atherosclerosis","volume":"28","author":"Winter","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0495","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1080\/07853890.2021.1974084","article-title":"Role and implications of the CXCL12\/CXCR4\/CXCR7 axis in atherosclerosis: still a debate","volume":"53","author":"Murad","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0500","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn8063","article-title":"Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias","volume":"8","author":"Yen","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2024.12.003_bb0505","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41593-023-01487-1","article-title":"Skull bone marrow channels as immune gateways to the central nervous system","volume":"26","author":"Mazzitelli","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2024.12.003_bb0510","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/ATVBAHA.119.311998","article-title":"Anticytokine immune therapy and atherothrombotic cardiovascular risk","volume":"39","author":"Ait-Oufella","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2024.12.003_bb0515","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41565-022-01161-w","article-title":"Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an \u03b11-antitrypsin-derived peptide motif","volume":"17","author":"Cruz","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tips.2024.12.003_bb0520","first-page":"150","article-title":"Convergence of nanomedicine and neutrophils for drug delivery","volume":"35","author":"Yuan","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.tips.2024.12.003_bb0525","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","article-title":"Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis","volume":"13","author":"Zhang","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tips.2024.12.003_bb0530","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotech."},{"key":"10.1016\/j.tips.2024.12.003_bb0535","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0540","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2024.12.003_bb0545","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/eurjpc\/zwae017","article-title":"The \u2018environmental exposome\u2019 as a target to reimagine the cardiovascular prevention","volume":"31","author":"Baragetti","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.tips.2024.12.003_bb0550","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2: \u2018N1\u2019 versus \u2018N2\u2019 TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2024.12.003_bb0555","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.immuni.2018.02.002","article-title":"Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions","volume":"48","author":"Evrard","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2024.12.003_bb0560","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41590-019-0571-2","article-title":"Programmed \u2018disarming\u2019 of the neutrophil proteome reduces the magnitude of inflammation","volume":"21","author":"Adrover","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2024.12.003_bb0565","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41590-022-01311-1","article-title":"Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress","volume":"23","author":"Montaldo","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2024.12.003_bb0570","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/leu.2011.62","article-title":"Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells","volume":"25","author":"Dar","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.tips.2024.12.003_bb0575","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0301-472X(01)00741-X","article-title":"The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow","volume":"29","author":"Shen","year":"2001","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tips.2024.12.003_bb0580","doi-asserted-by":"crossref","first-page":"20545","DOI":"10.1074\/jbc.271.34.20545","article-title":"The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor","volume":"271","author":"Ahuja","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2024.12.003_bb0585","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1432-1327.1998.2550067.x","article-title":"Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78","volume":"255","author":"Wuyts","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.tips.2024.12.003_bb0590","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.it.2022.09.008","article-title":"Human neutrophil kinetics: a call to revisit old evidence","volume":"43","author":"Koenderman","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tips.2024.12.003_bb0595","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.immuni.2019.01.002","article-title":"A neutrophil timer coordinates immune defense and vascular protection","volume":"50","author":"Adrover","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2024.12.003_bb0600","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cvr\/cvw024","article-title":"Temporal neutrophil polarization following myocardial infarction","volume":"110","author":"Ma","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0605","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s13577-023-00905-7","article-title":"Neutrophil (dys)function due to altered immuno-metabolic axis in type 2 diabetes: implications in combating infections","volume":"36","author":"Thimmappa","year":"2023","journal-title":"Hum. Cell"},{"key":"10.1016\/j.tips.2024.12.003_bb0610","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/eurheartj\/ehae131","article-title":"Understanding immunometabolism in cardiovascular disease: translating research into practice","volume":"45","author":"Norata","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2024.12.003_bb0615","doi-asserted-by":"crossref","first-page":"168","DOI":"10.33696\/immunology.5.182","article-title":"The high fat diet impacts the plasticity between fresh and aged neutrophils","volume":"5","author":"Baragetti","year":"2023","journal-title":"J. Cell Immunol."},{"key":"10.1016\/j.tips.2024.12.003_bb0620","doi-asserted-by":"crossref","DOI":"10.4110\/in.2020.20.e46","article-title":"Current understanding on the metabolism of neutrophils","volume":"20","author":"Jeon","year":"2020","journal-title":"Immune Netw."},{"key":"10.1016\/j.tips.2024.12.003_bb0625","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1038\/s41467-020-17402-2","article-title":"Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signaling","volume":"11","author":"Khatib-Massalha","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2024.12.003_bb0640","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","article-title":"Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis","volume":"144","author":"Edgar","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2024.12.003_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108387","article-title":"BCG vaccination induces long-term functional reprogramming of human neutrophils","volume":"33","author":"Moorlag","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2024.12.003_bb0650","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of myelopoiesis progenitors is an integral component of trained immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.12.003_bb0655","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.celrep.2017.11.010","article-title":"Hyperglycemia impairs neutrophil mobilization leading to enhanced metastatic seeding","volume":"21","author":"Fainsod-Levi","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2024.12.003_bb0660","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41569-023-00894-y","article-title":"Trained immunity in atherosclerotic cardiovascular disease","volume":"20","author":"Riksen","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2024.12.003_bb0665","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.3390\/ijms21124459","article-title":"Multifactorial activation of NLRP3 inflammasome: relevance for a precision approach to atherosclerotic cardiovascular risk and disease","volume":"21","author":"Baragetti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2024.12.003_bb0670","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.stem.2012.04.024","article-title":"Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways","volume":"11","author":"Westerterp","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2024.12.003_bb0675","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s44161-023-00388-7","article-title":"Bone marrow adipocytes fuel emergency hematopoiesis after myocardial infarction","volume":"2","author":"Zhang","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0680","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cvr\/cvac189","article-title":"Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1\u03b2 secretion","volume":"119","author":"Yalcinkaya","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2024.12.003_bb0685","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3324\/haematol.2018.205856","article-title":"Bone marrow adipose tissue-derived stem cell factor mediates metabolic regulation of hematopoiesis","volume":"104","author":"Zhang","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.tips.2024.12.003_bb0690","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/blood-2010-06-291716","article-title":"Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche","volume":"117","author":"Zheng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tips.2024.12.003_bb0695","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1038\/s41467-021-27460-9","article-title":"Free fatty-acid transport via CD36 drives \u03b2-oxidation-mediated hematopoietic stem cell response to infection","volume":"12","author":"Mistry","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2024.12.003_bb0700","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2362.2002.00959.x","article-title":"Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length","volume":"32","author":"Wanten","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.tips.2024.12.003_bb0705","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-291X(03)00488-1","article-title":"Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids","volume":"303","author":"Nilsson","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2024.12.003_bb0710","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2018-00824","article-title":"Effects of SGLT2 inhibitors on circulating stem and progenitor cells in patients with type 2 diabetes","volume":"103","author":"Bonora","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0715","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cmet.2019.08.015","article-title":"SGLT2 inhibition with empagliflozin increases circulating provascular progenitor cells in people with type 2 diabetes mellitus","volume":"30","author":"Hess","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2024.12.003_bb0720","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0725","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1189\/jlb.0608382","article-title":"Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?","volume":"85","author":"Maher","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.tips.2024.12.003_bb0730","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.CCM.0000201407.89977.EA","article-title":"Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery","volume":"34","author":"Chello","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0735","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1164\/rccm.201812-2328OC","article-title":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. a pilot randomized controlled clinical trial","volume":"200","author":"Sapey","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0740","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.athoracsur.2006.10.065","article-title":"Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery","volume":"83","author":"Chello","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.tips.2024.12.003_bb0745","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/eurheartj\/ehn138","article-title":"Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up","volume":"29","author":"Guasti","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2024.12.003_bb0750","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0003319715604098","article-title":"Statin therapy may not effect NLR and MPV levels in patients with hypercholesterolemia: a retrospective study","volume":"67","author":"Gungoren","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.tips.2024.12.003_bb0755","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022348","article-title":"Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"Cao","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.tips.2024.12.003_bb0760","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/bcp.12905","article-title":"Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms","volume":"81","author":"Sahebkar","year":"2016","journal-title":"Br. J. Clin. Pharma."},{"key":"10.1016\/j.tips.2024.12.003_bb0765","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcvm.2017.00084","article-title":"An interleukin-6 receptor antibody suppresses atherosclerosis in atherogenic mice","volume":"4","author":"Akita","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.tips.2024.12.003_bb0770","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1093\/eurheartj\/ehy286","article-title":"Post-ischaemic administration of the murine canakinumab-surrogate antibody improves outcome in experimental stroke","volume":"39","author":"Liberale","year":"2018","journal-title":"Eur. Heart J."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614724002694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614724002694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:52:04Z","timestamp":1777495924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614724002694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":155,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0165614724002694"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2024.12.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring neutrophils as therapeutic targets in cardiometabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}